Anorexia nervosa is a serious eating disorder characterized by self-imposed restriction of energy intake leading to significantly low body weight, an intense fear of gaining weight or persistent behavior that interferes with weight gain, and a disturbance in the way one’s body weight or shape is experienced. Although popular descriptions often emphasize food refusal, the core clinical problem is a maladaptive cognitive-emotional system: patients frequently experience overvaluation of weight and shape, heightened anxiety about weight-related cues, and sometimes denial of severity despite profound physiological consequences.
Epidemiology and risk factors include adolescence and young adulthood as common onset periods, with female sex assigned at birth historically overrepresented, though cases occur across genders. Predisposing factors include genetic susceptibility, temperament traits (e.g., perfectionism, harm avoidance), neurobiological vulnerabilities affecting reward and threat processing, and psychosocial influences such as dieting behaviors, peer and family dynamics, cultural pressures, and comorbid anxiety or obsessive-compulsive traits. Trauma history and neurodevelopmental factors can also contribute, and medical clinicians should screen broadly rather than attributing symptoms solely to willpower.
Clinical presentations vary by subtype. Restricting type involves dieting and/or fasting without recurrent binge eating or purging behaviors, while binge-eating/purging type includes episodes of overeating and/or compensatory behaviors such as self-induced vomiting, laxative or diuretic misuse. Diagnostic assessment focuses on body weight criteria, fear of weight gain, and body image disturbance. Differential diagnosis is essential: clinicians must distinguish anorexia nervosa from other causes of weight loss (malignancy, endocrine disease such as hyperthyroidism or adrenal insufficiency, inflammatory bowel disease), substance-induced appetite suppression, avoidant/restrictive food intake disorder, and eating disorders with different mechanisms such as bulimia nervosa or binge-eating disorder.
The pathophysiology is multifactorial. Chronic undernutrition triggers metabolic adaptation, including reduced resting energy expenditure, hormonal changes (e.g., altered leptin, ghrelin, cortisol rhythms), and dysregulation of gonadotropin and thyroid axes. Malnutrition also affects neurocircuitry: serotonergic and dopaminergic signaling, stress reactivity, and cognitive flexibility can be altered, which can perpetuate rigid eating behaviors. Cognitive symptoms—rumination about food, heightened threat sensitivity, and executive dysfunction—often improve with nutritional rehabilitation but may require parallel psychological treatment.
Medical complications can be life-threatening and require urgent evaluation. Cardiovascular consequences include bradycardia, hypotension, orthostatic changes, prolonged QT intervals, and increased risk of arrhythmias. Electrolyte disturbances—especially hypokalemia, hypomagnesemia, and refeeding-related shifts in phosphate—can precipitate rhabdomyolysis, seizures, or heart failure. Refeeding syndrome is a hallmark risk when restoring nutrition after prolonged starvation; it is characterized by electrolyte and fluid shifts driven by insulin-mediated metabolism. Clinically, prevention includes slow caloric reintroduction, thiamine supplementation, close monitoring of electrolytes, and careful adjustment of fluid strategy.
Gastrointestinal and endocrine effects include delayed gastric emptying, constipation, and nutrient deficiencies (iron, folate, B12, zinc, vitamin D). Skeletal consequences include osteopenia or osteoporosis due to hypoestrogenism and impaired bone remodeling. Hematologic abnormalities (anemia, leukopenia) may occur, and immune dysfunction can increase infection susceptibility.
Evidence-based treatment typically combines medical stabilization, nutritional rehabilitation, and psychotherapy. The primary goal is weight restoration and normalization of eating patterns. Family-based treatment (FBT) is strongly supported for adolescents, leveraging caregiver involvement to interrupt maladaptive control cycles and support consistent intake. Cognitive-behavioral therapy for eating disorders (CBT-E) addresses maintaining mechanisms such as dietary restraint, overvaluation of weight/shape, and maladaptive compensatory behaviors. For adults and some adolescents, enhanced approaches may include motivational interviewing, acceptance-based strategies, and relapse-prevention planning.
Pharmacotherapy is adjunctive rather than curative for the eating disorder itself. Management of comorbid depression, anxiety, or obsessive-compulsive symptoms may involve SSRIs or other agents, but medication effects on weight restoration are limited and should not replace structured nutritional and psychological interventions. In severe or refractory cases, multidisciplinary care, higher levels of intensity (partial hospitalization or inpatient programs), and specialized refeeding protocols may be required.
Prognosis depends on early detection, severity of malnutrition, chronicity, and the presence of medical complications. Recovery is possible, but relapse risk remains, emphasizing long-term follow-up, nutritional surveillance, and continued therapy. Clinicians should apply a compassionate, risk-informed approach that treats anorexia nervosa as a neurobehavioral condition requiring coordinated care, not a purely behavioral choice.
Source: @MariaMary72398
Mary Maria: @mediaDazzle12 Eat. #breaking
— @MariaMary72398 May 1, 2026
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
